BOLT — BOLT BIOTHERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About BOLT BIOTHERAPEUTICS INC (BOLT)
BOLT BIOTHERAPEUTICS INC (BOLT) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $40,840. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BOLT
How many top investors track BOLT
Only 1 tracked investor report this position.
BOLT Ownership Composition
How BOLT BIOTHERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting BOLT
- Ken GriffinMar 31, 2026Citadel AdvisorsShares10.1KValue$40.8K% Portfolio0.00%
Recent activity
- New$40.8KMay 15, 2026
Frequently asked questions
- How many institutional investors hold BOLT?
- 1 tracked institutional investor disclosed a position in BOLT (BOLT BIOTHERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of BOLT?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in BOLT, valued at $40,840.
- Did institutional ownership of BOLT increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited BOLT.
- Where does this BOLT ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.